Howard Hughes Medical Institute’s Credit Acceptance CACC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-78,918
Closed -$20.3M 46
2017
Q2
$20.3M Buy
78,918
+28,082
+55% +$6.15M 3.7% 4
2017
Q1
$10.1M Buy
50,836
+12,548
+33% +$2.53M 1.86% 6
2016
Q4
$8.33M Buy
38,288
+2,106
+6% +$408K 1.9% 5
2016
Q3
$7.28M Sell
36,182
-5,503
-13% -$1.08M 1.87% 10
2016
Q2
$7.71M Buy
41,685
+6,232
+18% +$1.14M 2.59% 6
2016
Q1
$6.44M Buy
35,453
+15,401
+77% +$2.94M 1.42% 14
2015
Q4
$4.29M Buy
+20,052
New +$4.1M 0.65% 27

Other funds holding CACC

Howard Hughes Medical Institute's CACC Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Credit Acceptance (CACC) in Q3 2017, closing a stake of 78,918 shares — an estimated $20.3M sold.

Howard Hughes Medical Institute first reported a position in CACC in Q4 2015 and held it in 7 quarters. The position peaked at $20.3M in Q2 2017. 173 funds tracked by Wall St. Rank hold CACC as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Credit Acceptance position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 78,918 Credit Acceptance shares in Q3 2017, an estimated $20.3M.
  • Howard Hughes Medical Institute first reported a position in Credit Acceptance in Q4 2015 and held it in 7 quarters.
  • Howard Hughes Medical Institute's Credit Acceptance position peaked at $20.3M in Q2 2017.
  • 173 funds tracked by Wall St. Rank held Credit Acceptance as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.